Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer

Radiotherapy and Oncology

Volumn 79, Issue 1, 2006, Pages 59-64

  Guckenberger, Matthias ^a   Pohl, Fabian ^a   Baier, Kurt ^a   Meyer, Juergen ^a   Vordermark, Dirk ^a   Flentje, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anal canal; IMRT; Planning study; Prostate cancer; Rectal distension; Toxicity

Indexed keywords

ANUS; ARTICLE; BLADDER; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMUR HEAD; HEALTH CARE UTILIZATION; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; INTESTINE DISTENSION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RECTUM; RISK ASSESSMENT; STANDARD; TREATMENT PLANNING;

ALGORITHMS; DILATATION, PATHOLOGIC; EVALUATION STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RETROSPECTIVE STUDIES;

EID: 33646187273     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.03.004     Document Type: Article

References (29)

1. Boersma L.J., van den Brink M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
2. Bos L.J., Damen E.M., et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys 52 (2002) 254-265
3. de Crevoisier R., Tucker S.L., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 965-973
4. Dearnaley D.P., Khoo V.S., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353 (1999) 267-272
5. Fenwick J.D., Khoo V.S., Nahum A.E., Sanchez-Nieto B., and Dearnaley D.P. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys 49 (2001) 473-480
6. Fiorino C., Cozzarini C., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 64 (2002) 1-12
7. Fiorino C., Gianolini S., and Nahum A.E. A cylindrical model of the rectum: comparing dose-volume, dose-surface and dose-wall histograms in the radiotherapy of prostate cancer. Phys Med Biol 48 (2003) 2603-2616
8. Fokdal L., Honore H., Hoyer M., and von der Maase H. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 74 (2005) 203-210
9. Ghilezan M., Yan D., Liang J., Jaffray D., Wong J., and Martinez A. Online image-guided intensity-modulated radiotherapy for prostate cancer: how much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 60 (2004) 1602-1610
10. Greco C., Mazzetta C., et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 69 (2003) 215-222
11. Heemsbergen W.D., Hoogeman M.S., Hart G.A., Lebesque J.V., and Koper P.C. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1011-1018
12. Jackson A., Skwarchuk M.W., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. Part II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
13. Karlsdottir A., Johannessen D.C., Muren L.P., Wentzel-Larsen T., and Dahl O. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 71 (2004) 43-53
14. Koper P.C., Heemsbergen W.D., et al. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1072-1082
15. Kupelian P., Kuban D., et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 61 (2005) 415-419
16. Leibel S.A., Fuks Z., et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol 30 (2003) 596-615
17. MacKay R.I., Hendry J.H., Moore C.J., Williams P.C., and Read G. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br J Radiol 70 (1997) 517-526
18. Pinkawa M., Fischedick K., et al. Dose-volume impact in high-dose-rate iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer-a phase II study. Radiother Oncol (2005)
19. Pollack A., Hanlon A.L., Horwitz E.M., Feigenberg S.J., Uzzo R.G., and Hanks G.E. Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol 171 (2004) 1132-1136
20. Pollack A., Zagars G.K., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
21. Roach M. 3rd Commentary on increased risk of biochemical and local failure in patients with a distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 949-950
22. Schultheiss T.E., Lee W.R., Hunt M.A., Hanlon A.L., Peter R.S., Hanks G.E., and Late G.I. and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 3-11
23. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., and Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
24. Tucker S.L., Dong L., et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 1589-1601
25. Vordermark D., Schwab M., Flentje M., Sailer M., and Kolbl O. Chronic fatigue after radiotherapy for carcinoma of the prostate: correlation with anorectal and genitourinary function. Radiother Oncol 62 (2002) 293-297
26. Vordermark D., Schwab M., Ness-Dourdoumas R., Sailer M., Flentje M., and Koelbl O. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 69 (2003) 209-214
27. Yeoh E.E., Holloway R.H., Robert J.F., et al. Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate. Am J Gastroenterol 99 (2004) 361-369
28. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55 (2000) 241-249
29. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881